This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

William J. Moran, DMD, MD; Joseph A. Toljanic, DDS; William R. Panje, MD

Arch Otolaryngol Head Neck Surg. 1996;122(1):46-50.

Abstract
Objective
To evaluate the use of endosseous transcutaneous implants to retain removable facial prostheses for the rehabilitation of orbital defects.

Setting
Tertiary referral center.

Patients
Six patients with a history of facial defects secondary to orbital exenteration for cancer ablation.

Outcome Measures
Clinically noted functional and cosmetic results, patient reports of satisfaction, and complications encountered.

Results
Twenty-three of 25 implants were integrated (postoperative period, 13 to 65 months; mean, 44.2 months), representing an integration success rate of 92%. All patients were successfully wearing implant-retained prostheses after 48.3 months (postprosthesis delivery period, 1 to 48.3 months; mean, 24.5 months). Overall patient satisfaction was very high.

Conclusions
Implant-retained prosthetics represent a safe and effective treatment option. It is anticipated that this treatment will become the standard of rehabilitative care for patients with orbital defects.

(Arch Otolaryngol Head Neck Surg. 1996;122:46-50)

Author Affiliations
From the Sections of Otolaryngology and Maxillofacial Prosthesis, The University of Chicago Medical Center (Drs Moran and Toljanic), and the Department of Otolaryngology, Rush-Presbyterian—St Luke's Medical Center (Dr Panje), Chicago, Ill.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?